Clinical Trials Logo

Clinical Trial Summary

A randomized, double-blind trial of docosahexaenoic and arachidonic acid supplementation in breast-fed preterm infants

Background:

Docosahexaenoic acid (DHA) and arachidonic acid (AA) are essential for preterm infants. Human milk and preterm formulas contain DHA and AA, but at lower concentrations than required to approximate utero accretion rate.

Objective:

To evaluate the effect of a high dose DHA and AA supplement to breast-fed preterm infants in the early neonatal period. Primary endpoints are neurodevelopment at 6 and 20 months of age.

Design:

A randomized double-blind placebo-controlled study is carried out in four Norwegian neonatal centers.

Subjects and methods:

Infants with birth weight < 1.5 kg are randomized to either an intervention or a control group. All infants receive fortified human milk, and a daily dose of 0.5 ml study oil per 100 ml milk. Infants in the intervention group receive oil with DHA and AA (Formulaid, Martek, USA), while the control oil contains vegetable oil without DHA or AA. Blood samples are collected at birth (cord), and at start and stop of the intervention. Plasma is analyzed for fatty acid pattern using high performance liquid chromatography.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00226187
Study type Interventional
Source University of Oslo
Contact
Status Completed
Phase N/A
Start date December 2003

See also
  Status Clinical Trial Phase
Completed NCT02379728 - Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth N/A
Withdrawn NCT01335919 - Neonatal Non-Invasive Hemoglobin Determination N/A
Completed NCT00114543 - Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight Phase 3
Completed NCT00011362 - Dexamethasone Therapy in VLBW Infants at Risk of CLD Phase 3
Active, not recruiting NCT02944682 - Household Air Pollution and Health: A Multi-country LPG Intervention Trial N/A
Recruiting NCT00005889 - Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion N/A
Completed NCT01203423 - Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study
Completed NCT01223287 - Physiologic Definition of Bronchopulmonary Dysplasia N/A
Not yet recruiting NCT04866277 - Experimental Study to Reduce Low Birthweight N/A
Completed NCT00593801 - Erythropoietin Treatment in Extremely Low Birth Weight Infants N/A
Completed NCT00109525 - Early Diagnosis of Candidiasis in Premature Infants
Completed NCT00067613 - Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia N/A
Completed NCT01223261 - Observational Study of Surgical Treatment of Necrotizing Enterocolotis
Completed NCT05358509 - Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial Phase 4
Completed NCT02377817 - Halifax PrenaBelt Trial N/A
Completed NCT01455636 - Preventing Linear Growth Faltering Among Low Birth Weight Infants in Bangladesh Phase 3
Completed NCT00349726 - Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants Phase 2
Completed NCT01222364 - Delayed Cord Clamping in VLBW Infants Phase 1/Phase 2
Completed NCT01203449 - Development of Standards for the New Ballard Maturation Score N/A
Completed NCT00873847 - Cerebral Function Monitoring in Premature Infants N/A